Muhammad Zubair

Prof. Dr. Muhammad Zubair

Riphah International University, Islamabad, Islāmābād, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in IEEE Access
Verified
Journal Article
Open access
SMShahid Mehmood
Shahid Mehmood
Taher M. GhazalTaher M. Ghazal
Taher M. Ghazal
MKMuhammad Adnan Khan
Muhammad Adnan Khan
Muhammad ZubairMuhammad Zubair
Muhammad Zubair
MNMuhammad Tahir Naseem
Muhammad Tahir Naseem
Munir AhmadMunir Ahmad
Munir Ahmad
Cancer accounts for a huge mortality rate due to its aggressiveness, colossal potential of metastasis, and heterogeneity (causing resistance against chemotherapy). Lung and colon cancers are among the most prevalent types of cancer around the globe that can occur in both males and females. Early and accurate diagnosis of these cancers can substantially improve the quality of treatment as well as the survival rate of cancer patients. We propose a highly accurate and computationally efficient model for the swift and accurate diagnosis of lung and colon cancers as an alternative to current cancer detection methods. In this study, a large dataset of lung and colon histopathology images was employed for training and the validation process. The dataset is comprised of 25000 histopathology images of lung and colon tissues equally divided into 5 classes. A pretrained neural network (AlexNet) was tuned by modifying the four of its layers before training it on the dataset. Initial classification results were promising for all classes of images except for one class with an overall accuracy of 89%. To improve the overall accuracy and keep the model computationally efficient, instead of implementing image enhancement techniques on the entire dataset, the quality of images of the underperforming class was improved by applying a contrast enhancement technique which is fairly simple and efficient. The implementation of the proposed methodology has not only improved the overall accuracy from 89% to 98.4% but has also proved computationally efficient.

2 October 2022 in Sensors
Verified
Journal Article
Open access
PDF file
MNMuhammad Umar Nasir
Muhammad Umar Nasir
Muhammad ZubairMuhammad Zubair
Muhammad Zubair
Taher M. GhazalTaher M. Ghazal
Taher M. Ghazal
MKMuhammad Farhan Khan
Muhammad Farhan Khan
Munir AhmadMunir Ahmad
Munir Ahmad
WMWathiq Mansoor
Wathiq Mansoor
Kidney cancer is a very dangerous and lethal cancerous disease caused by kidney tumors or by genetic renal disease, and very few patients survive because there is no method for early prediction of kidney cancer. Early prediction of kidney cancer helps doctors start proper therapy and treatment for the patients, preventing kidney tumors and renal transplantation. With the adaptation of artificial intelligence, automated tools empowered with different deep learning and machine learning algorithms can predict cancers. In this study, the proposed model used the Internet of Medical Things (IoMT)-based transfer learning technique with different deep learning algorithms to predict kidney cancer in its early stages, and for the patient’s data security, the proposed model incorporates blockchain technology-based private clouds and transfer-learning trained models. To predict kidney cancer, the proposed model used biopsies of cancerous kidneys consisting of three classes. The proposed model achieved the highest training accuracy and prediction accuracy of 99.8% and 99.20%, respectively, empowered with data augmentation and without augmentation, and the proposed model achieved 93.75% prediction accuracy during validation. Transfer learning provides a promising framework with the combination of IoMT technologies and blockchain technology layers to enhance the diagnosing capabilities of kidney cancer.

31 May 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
TGTaher M. Ghazal
Taher M. Ghazal
HHHussam Al Hamadi
Hussam Al Hamadi
MNMuhammad Umar Nasir
Muhammad Umar Nasir
Atta ur RahmanAtta ur Rahman
Atta ur Rahman
MGMohammed Gollapalli
Mohammed Gollapalli
CYChan Yeob Yeun
Chan Yeob Yeun
Fatal diseases like cancer, dementia, and diabetes are very dangerous. This leads to fear of death if these are not diagnosed at early stages. Computer science uses biomedical studies to diagnose cancer, dementia, and diabetes. With the advancement of machine learning, there are various techniques which are accessible to predict and prognosis these diseases based on different datasets. These datasets varied (image datasets and CSV datasets) around the world. So, there is a need for some machine learning classifiers to predict cancer, dementia, and diabetes in a human. In this paper, we used a multifactorial genetic inheritance disorder dataset to predict cancer, dementia, and diabetes. Several studies used different machine learning classifiers to predict cancer, dementia, and diabetes separately with the help of different types of datasets. So, in this paper, multiclass classification proposed methodology used support vector machine (SVM) and K-nearest neighbor (KNN) machine learning techniques to predict three diseases and compared these techniques based on accuracy. Simulation results have shown that the proposed model of SVM and KNN for prediction of dementia, cancer, and diabetes from multifactorial genetic inheritance disorder achieved 92.8% and 92.5%, 92.8% and 91.2% accuracy during training and testing, respectively. So, it is observed that proposed SVM-based dementia, cancer, and diabetes from multifactorial genetic inheritance disorder prediction (MGIDP) give attractive results as compared with the proposed model of KNN. The application of the proposed model helps to prognosis and prediction of cancer, dementia, and diabetes before time and plays a vital role to minimize the death ratio around the world.

9 June 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
MNMuhammad Umar Nasir
Muhammad Umar Nasir
TGTaher M. Ghazal
Taher M. Ghazal
MKMuhammad Adnan Khan
Muhammad Adnan Khan
Muhammad ZubairMuhammad Zubair
Muhammad Zubair
Atta ur RahmanAtta ur Rahman
Atta ur Rahman
CYChan Yeob Yeun
Chan Yeob Yeun
In the world, in the past recent five years, breast cancer is diagnosed about 7.8 million women’s and making it the most widespread cancer, and it is the second major reason for women’s death. So, early prevention and diagnosis systems of breast cancer could be more helpful and significant. Neural networks can extract multiple features automatically and perform predictions on breast cancer. There is a need for several labeled images to train neural networks which is a nonconventional method for some types of data images such as breast magnetic resonance imaging (MRI) images. So, there is only one significant solution for this query is to apply fine-tuning in the neural network. In this paper, we proposed a fine-tuning model using AlexNet in the neural network to extract features from breast cancer images for training purposes. So, in the proposed model, we updated the first and last three layers of AlexNet to detect the normal and abnormal regions of breast cancer. The proposed model is more efficient and significant because, during the training and testing process, the proposed model achieves higher accuracy 98.44% and 98.1% of training and testing, respectively. So, this study shows that the use of fine-tuning in the neural network can detect breast cancer using MRI images and train a neural network classifier by feature extraction using the proposed model is faster and more efficient.

29 June 2022 in IEEE Access
Verified
Journal Article
Open access
Atta ur RahmanAtta ur Rahman
Atta ur Rahman
MNMuhammad Umar Nasir
Muhammad Umar Nasir
MGMohammed Gollapalli
Mohammed Gollapalli
Muhammad ZubairMuhammad Zubair
Muhammad Zubair
MSMuhammad Aamer Saleem
Muhammad Aamer Saleem
Amir MosaviAmir Mosavi
Amir Mosavi
A major and essential issue in biomedical research is to predict genome disorder. Genome disorders cause multivariate diseases like cancer, dementia, diabetes, cystic fibrosis, leigh syndrome, etc. which are causes of high mortality rates around the world. In past, theoretical and explanatory-based approaches were introduced to predict genome disorder. With the development of technology, genetic data were improved to cover almost genome and protein then machine and deep learning-based approaches were introduced to predict genome disorder. Parallel machine and deep learning approaches were introduced. In past, many types of research were conducted on genome disorder prediction using supervised, unsupervised, and semi-supervised learning techniques, most of the approaches using binary problem prediction using genetic sequence data. The prediction results of these approaches were uncertain because of their lower accuracy rate and binary class prediction techniques using genome sequence data but not genome disorder patients’ data with his/her history. Most of the techniques used Ribonucleic acid (RNA) gene sequence and were not often capable of handling bid data effectively. Consequently, in this study, the AlexNet as an effective convolutional neural network architecture proposed to develop an advance genome disorder prediction model (AGDPM) for predicting genome multi classes disorder using a large amount of data. AGDPM tested and compare with the pre-trained AlexNet neural network model and AGDPM gives the best results with 89.89% & 81.25% accuracy of training and testing respectively. So, the advance genome disorder prediction model shows the ability to efficiently predict genome disorder and can process a large amount of patients’ genome disorder data with a multi-class prediction method. AGDPM has proved that it is capable to predict single gene inheritance disorder, mitochondrial gene inheritance disorder, and multifactorial gene inheritance disorder with respect to various statistical performance parameters. So, with the help of AGDPM biomedical research will be improved in terms to predict genetic disorders and put control on high mortality rates.

1 January 2022 in Computers, Materials & Continua
Verified
Journal Article
Open access
PDF file
MNMuhammad Umar Nasir
Muhammad Umar Nasir
MKMuhammad Adnan Khan
Muhammad Adnan Khan
Muhammad ZubairMuhammad Zubair
Muhammad Zubair
TGTaher M. Ghazal
Taher M. Ghazal
RSRaed A. Said
Raed A. Said
HHHussam Al Hamadi
Hussam Al Hamadi
One of the most difficult jobs in the post-genomic age is identifying a genetic disease from a massive amount of genetic data. Furthermore, the complicated genetic disease has a very diverse genotype, making it challenging to find genetic markers. This is a challenging process since it must be completed effectively and efficiently. This research article focuses largely on which patients are more likely to have a genetic disorder based on numerous medical parameters. Using the patient’s medical history, we used a genetic disease prediction algorithm that predicts if the patient is likely to be diagnosed with a genetic disorder. To predict and categorize the patient with a genetic disease, we utilize several deep and machine learning techniques such as Artificial neural network (ANN), K-nearest neighbors (KNN), and Support vector machine (SVM). To enhance the accuracy of predicting the genetic disease in any patient, a highly efficient approach was utilized to control how the model can be used. To predict genetic disease, deep and machine learning approaches are performed. The most productive tool model provides more precise efficiency. The simulation results demonstrate that by using the proposed model with the ANN, we achieve the highest model performance of 85.7%, 84.9%, 84.3% accuracy of training, testing and validation respectively. This approach will undoubtedly transform genetic disorder prediction and give a real competitive strategy to save patients’ lives.